Illumina to Webcast Presentation at UBS Global Life Sciences Conference
Posted on: Wednesday, 20 September 2006, 06:00 CDT
Illumina, Inc. (NASDAQ:ILMN) announced today that Jay Flatley, President and CEO, will present an overview of the Company's commercial and product development activity at the upcoming UBS Global Life Sciences Conference in New York, New York (USA).
Mr. Flatley's presentation will take place live at the conference at 9:00 a.m. Eastern Time and the recorded webcast will be played on or about 11:00 a.m. Pacific Time (PT) on Monday, September 25, 2006. The following webcast URL provides access to the presentation as well as an audio file that will be available for 30 days following the event: http://events.streamx.us/US/event/EventDetails.aspx?id=ubs20060925
Illumina (www.illumina.com) is developing next-generation tools that permit large-scale analysis of genetic variation and function. The Company's proprietary BeadArray(TM) technology - now used in leading genome centers around the world - provides the throughput, cost effectiveness and flexibility to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics. This information will help pave the way to personalized medicine by correlating genetic variation and gene function with particular disease states, enhancing drug discovery, allowing diseases to be detected earlier and more specifically, and permitting better choices of drugs for individual patients.
Source: Business Wire
Related Articles
- Illumina to Conduct Large-Scale Genotyping for UK-Based Research Groups Studying Molecular Basis of Prostate Cancer
- Illumina Awarded Genotyping Contract By SAIC-Frederick, Inc. For Cancer Genetics Marker Susceptibility (CGEMS) Study
- Illumina Appoints Matt Posard to Lead Worldwide Marketing
- North Shore-Long Island Jewish Health System to Use Illumina Whole-Genome Genotyping Solutions to Support Study of Inflammatory Bowel Disease
- Center for Inherited Disease Research (CIDR) to Use Illumina Whole-Genome Genotyping Solutions to Support Study for Finland-United States Type 2 Diabetes Collaboration
- Illumina Advances Genetic Analysis of Cancer With Powerful Tools for Characterizing Chromosomal Changes
- Illumina Conducting Large-Scale Poultry Genotyping Project for Aviagen; Results to Pave Way for Improved Breeding Technologies
- PARC Team Purchases Illumina Genotyping Solutions for Study of Pharmacogenomics of Cardiovascular Disease
- Max-Planck Institute of Psychiatry to Use Illumina Whole-Genome Arrays for Large-Scale Genotyping Studies
- National Cancer Institute Purchases Production-Scale BeadLab From Illumina For Array-Based Genetic Analysis
 |
 |
User Comments (0)
RSS Feeds